# Prosonix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prosonix

- Industry: Pharmaceuticals
- Headquarters: Oxford, UK
- Website: www.prosonix.co.uk
- Total disclosed funding: $26M
- Latest round: Series B (Oct 5, 2012)
- Investors on record: 6

## About

Prosonix is an innovative company specializing in ultrasonic atomization technologies for the pharmaceutical sector, focusing on advanced nebulizers that improve drug delivery and patient outcomes in respiratory therapies.Founded in 2006 in Oxford, UK, Prosonix develops ultrasonic nebulization solutions for the healthcare sector. The company underwent a significant transformation when it was acquired by Circassia Ltd in May 2015 for GBP 70 million, marking a pivotal change in its operational strategy. Circassia Ltd, a portfolio company of various investment firms, led this acquisition, which has influenced Prosonix's business trajectory.Prosonix.co.uk specializes in advanced ultrasonic nebulizers that efficiently deliver aerosolized medications. These devices convert liquid medications into fine mist particles for inhalation, enhancing treatment efficacy in respiratory therapies. Their product range is primarily utilized in clinical settings across Europe, North America, and Asia, catering to healthcare institutions and pharmaceutical companies involved in inhalable drug formulations.In 2017, Prosonix generated revenue of GBP 59,675,159.50 with an EBITDA of GBP -150,412,335, reflecting the financial dynamics of the company during that period.Prosonix plans to leverage recent funding to enhance product development and expand its market reach. The acquisition by Circassia Ltd in May 2015 has positioned Prosonix for growth, with future initiatives focused on launching new products and entering emerging markets in Asia by 2025. The funding will support these strategic expansions and product innovations.

## Funding rounds

- Series B, Oct 5, 2012, $8M — Ventech, Gilde Healthcare, Gimv, Quest Management, Solon Ventures, Entrepreneurs Fund Management
- Series B, Jun 29, 2011, $18M — Ventech, Gilde Healthcare, Quest Management, Solon Ventures, Entrepreneurs Fund Management

## Investors

- Ventech (https://capitalatlas.ai/funds/ventech) — Series B
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series B
- Quest Management (https://capitalatlas.ai/funds/quest-management) — Series B
- Solon Ventures (https://capitalatlas.ai/funds/solon-ventures) — Series B
- Entrepreneurs Fund Management (https://capitalatlas.ai/funds/entrepreneurs-fund-management) — Series B
- Gimv (https://capitalatlas.ai/funds/gimv) — Series B